JONATHAN G. DRACHMAN - 22 Jun 2022 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Director
Signature
/s/ Jonathan Drachman by Georgia Erbez, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
22 Jun 2022
Net transactions value
$0
Form type
4
Filing time
24 Jun 2022, 18:45:22 UTC
Previous filing
14 Feb 2022
Next filing
04 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (Right to Buy) Award $0 +10,167 $0.000000 10,167 22 Jun 2022 Common Stock 10,167 $2.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.